Moffitt identifies novel therapeutic targets in cutaneous squamous cell carcinoma

(H. Lee Moffitt Cancer Center & Research Institute) Researchers at Moffitt Cancer Center want to devise better therapeutic strategies for patients with cutaneous squamous cell carcinoma (cuSCC) by improving their understanding of how the disease develops. In a new article published online ahead of print in the journal Cancer Research, Moffitt scientists report on their identification of potential therapeutic targets for cuSCC.